BOT 2.70% 36.0¢ botanix pharmaceuticals ltd

Bot Chart, page-13366

  1. 650 Posts.
    lightbulb Created with Sketch. 409
    I'm not generally an angry person, I get a bit frustrated reading some of the rubbish on here. I get that everyone is a bit buzzed, but its pretty important to remain rational. It shouldn't affect me, but it does.

    Anyway, Qbrexza's parent Journey Medical, has a MC of USD100m and they have a Rosacea product to boot. Qbrexza has been in the market since 2018.

    Its not all champagne and strawberries folks.

    Also, I'm an investor, not a trader. I would rather see a stable increase in SP rather than this volatility.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.